Biotechnology company Nuclera has introduced an antibody screening service to enable quick access to high-quality proteins and advance AI-driven discovery. “Antibodies are one of the most important ...

In April 2025, the US Food and Drug Administration (FDA) announced plans to phase out certain animal testing requirements, ...

Sino Biological, the regional subsidiary of global life science reagent and service provider Sino Biological, has recently ...

The collaboration aims to discover novel therapies for liver disease, including metabolic dysfunction-associated ...

Through this agreement, Cellular Intelligence will advance the continued clinical development of the cell therapy Parkinson’s program and provide disease-modifying therapy for p ...

Life science product company Bio-Rad Laboratories has launched the PTC Harmony Thermal Cycler line. The line is designed to ...

By using this site, you agree to the Privacy Policy and Terms of Use. Accept ...

Globally, RSV is responsible for an immense health and economic burden, causing an estimated 33 million new ALRI cases and over three million hospitalisations each year in children under the age of ...

Lundbeck will be presenting its research at the 2026 Alzheimer’s and Parkinson’s Disease conference Lundbeck has shared that new data from a Phase 1b proof-of-mechanism trial of Lu AF28996, a novel ...

The United Kingdom will create a new AI research laboratory to improve AI systems in healthcare, science, transportation and everyday technology. “AI is already doing things we could never have ...